T follicular helper cells: linking cancer immunotherapy and immune-related adverse events (vol 9, e002588, 2021)

被引:0
|
作者
Baumjohann, D.
Brossart, P.
机构
关键词
D O I
10.1136/jitc-2021-002588corr1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Tofacitinib for the treatment of immune-related adverse events in cancer immunotherapy: A multi-center study
    Liu, Q.
    Liu, M.
    Zou, Z.
    Lin, J.
    Wang, Y.
    Zhang, N.
    Zhao, L.
    Zhou, J.
    Zhou, H.
    Zhou, X.
    Jiao, X.
    Yu, Y.
    Liu, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S1633 - S1633
  • [32] Immune-Related Adverse Events in Cancer Immunotherapy: How Often Do We See Them?
    Scaglioni, Valeria
    Scolnik, Marina
    Lastiri, Jose Maria
    Lupinacci, Lorena
    Soriano, Enrique R.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [33] Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy
    Dimitriou, Florentia
    Hogan, Sabrina
    Menzies, Alexander M.
    Dummer, Reinhard
    Long, Georgina, V
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 214 - 224
  • [34] The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy
    Calabrese, Leonard
    Mariette, Xavier
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (02) : 162 - 164
  • [35] EULAR RECOMMENDATIONS FOR THE DIAGNOSIS AND THE MANAGEMENT OF RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS DUE TO CANCER IMMUNOTHERAPY
    Kostine, Marie
    Finckh, Axel
    Bingham, Clifton
    Visser, Karen
    Leipe, Jan
    Schulze-Koops, Hendrik
    Choy, Ernest
    Benesova, Karolina
    Radstake, Timothy R.
    Cope, Andrew
    Lambotte, Oliver
    Gottenberg, Jacques-Eric
    Allenbach, Yves
    Visser, Marianne
    Rusthoven, Cindy
    Thomasen, Lone
    Jamal, Shahin
    Marabelle, Aurelien
    Larkin, James
    Haanen, John
    Calabrese, Leonard
    Mariette, Xavier
    Schaeverbeke, Thierry
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 158 - 158
  • [36] Chronic immune-related adverse events following immunotherapy administration in a gynecologic cancer patient population
    Chalif, Julia
    Morton, Molly
    Scuiva, Jessica
    Fulton, Jessica
    Marcu, Ioana
    Gonzalez, Anna
    Bixel, Kristin
    Cohn, David
    Cosgrove, Casey
    Copeland, Larry
    Nagel, Christa
    Backes, Floor
    O'Malley, David
    Chambers, Laura
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S406 - S408
  • [37] Immune-Related Adverse Events are Associated with Survival in Chinese Lung Cancer Patients Treated With Immunotherapy
    Zhang, Y.
    Yan, H.
    Zeng, L.
    Zhou, G.
    Wu, Y.
    Qin, H.
    Yang, N.
    Huang, Z.
    Yang, D.
    Zhang, X.
    Zhang, Y.
    Graham-Siegenthaler, K.
    Walls, R.
    Hamzic, S.
    He, Y.
    Mohindra, R.
    Chandler, S.
    Li, Z.
    Luo, R.
    Saha, A.
    Hammer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S270 - S270
  • [38] Letter responds to the comment in 'immune thrombocytopenia of haematological immune-related adverse events in cancer immunotherapy: Most and mighty'
    Michot, Jean-Marie
    Lazarovici, Julien
    Tieu, Ashley
    Champiat, Stephane
    Voisin, Anne-Laure
    Ebbo, Mikael
    Godeau, Bertrand
    Michel, Marc
    Ribrag, Vincent
    Lambotte, Olivier
    EUROPEAN JOURNAL OF CANCER, 2020, 134 : 60 - 61
  • [39] Predicting immune-related adverse events using biomarkers in early-phase cancer immunotherapy trials
    Fairfax, B. P.
    Schmid, V. C.
    Lamparter, D. F.
    Kam-Thong, T.
    Scepanovic, P.
    Duchateau-Nguyen, G.
    Roller, A.
    Mohindra, R.
    Karanikas, V.
    Heinzmann, D.
    Adams, C.
    Mycroft, S. L.
    Stadler, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S279 - S279
  • [40] Impact of comorbidity burden on immune-related adverse events and survival among older adults with cancer on immunotherapy
    Faucheux, Andrew T.
    Klepin, Heidi D.
    Levine, Beverly J.
    Quattlebaum, Alexander M.
    Bloomer, Chance H.
    Khoury, Lara M.
    Hunting, John
    Elko, Catherine A.
    Olson, Eric
    Lycan, Thomas William
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)